[Electroclinical evaluation of a new antiepileptic drug Ro 5-4023].
D000284:Administration, Oral; D000293:Adolescent; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001552:Benzazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004827:Epilepsy / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007223:Infant; D007659:Ketones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D009574:Nitro Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013607:Tablets; D013997:Time Factors
D000927:Anticonvulsants; D001552:Benzazepines; D007659:Ketones; D009574:Nitro Compounds; D013607:Tablets
Valoraciòn electroclìnica de un nuevo medicamento antiepilèptico, el Ro 5-4023.